First Online: 15 September 2015
: R.J.M. declares that he has received research support from Amgen, AstraZeneca, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Novartis, Otsuka, and ResMed. He has also received honoraria from Thoratec and has served on an advisory board for Luitpold Pharmaceuticals, Inc. C.M.O. receives research support from Astellas, Gilead, Otsuka, and Roche Diagnostics, and is a consultant for HeartWare.